People aged 12+ who have Down’s syndrome are among thousands of the UK’s most vulnerable people who will be the first in the world to be offered life-saving, cutting-edge antiviral and antibody treatments that they can take from home. It is hoped the treatments can help protect those most at risk from the virus over the winter months.
Read more information from the Down's Syndrome Association here.
More news articles
Research Study- Grammar Learning in Down Syndrome
5th Jul 2022
Volunteers needed for a research study
Read more...Research Study on the Health of People with Down Syndrome
5th Jul 2022
The London Down Syndrome research group (LonDownS) based at King’s College London are carrying out a new research study
Read more...